BioSpace News Archive

BIJUVA is the only FDA-approved Therapy Combining Bio-identical Estradiol and Progesterone for Moderate to Severe Vasomotor Symptoms due to Menopause in a Single Capsule

Leading Healthcare Investor Will Provide TherapeuticsMD with Strategic Growth Capital

Aethlon Medical, Inc. (Nasdaq: AEMD), today released the following shareholder update authored by its CEO, Timothy C. Rodell, M.D.

BetterUp’s personalized leadership development platform disrupts learning and development industry; provides measurable behavior change

“The life sciences sector in Georgia is resilient and growing.” This according to a report previewed today by RTI International (RTI) for Georgia Bio. “ From 2007 to 2017, employment in life sciences grew by 14.9%, compared to 7.7% nationally, and 8.7% growth in private employment across all industries in the state.”

Finalist for both The Support Services Supplier of the Year Award and the Compliance and Integrity award, ultimately winning the Support Services Supplier of the Year.

A May 26th Colorado Springs Fertility Conference will feature a keynote address from integrative medicine pioneers Paul C. Magarelli, MD, Ph.D. and Diane K. Cridennda, L.Ac, FABORM.

Cannabics Pharmaceuticals Inc. announced that it has obtained approval for a nationwide Israeli multisite clinical study on the antitumor properties of cannabinoid compounds on primary cancer biopsies.

Investment is Led by Goldman Sachs Principal Strategic Investments

Michael O’Hara joined as vice president of quality assurance and Rita Paparazzo, MBA, as senior director of clinical operations.